Hypoaldosteronism natural history, complications and prognosis: Difference between revisions
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
If left untreated, hypoaldosteronism | If left untreated, hypoaldosteronism leads to hyperkalemia which can alter the function of cardiac conduction pathways. Depending upon the level of hyperkalemia, hypoaldosteronism can be a life threatening condition. Common complications of hypoaldosteronism include hyperkalemia, metabolic acidosis, hypotension, hypovolemia and hyponatremia. Depending on the extent of the hyperkalemia and underlying renal or adrenal condition at the time of diagnosis, the prognosis of hypoaldosteronism may vary. Prognosis is generally good for patients of hypoaldosteronism who receive treatment. Untreated patients risk having hyperkalemia which is associated with cardiac arrhythmias that can be fatal. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== |
Revision as of 14:52, 31 August 2017
Hypoaldosteronism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypoaldosteronism natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hypoaldosteronism natural history, complications and prognosis |
FDA on Hypoaldosteronism natural history, complications and prognosis |
CDC on Hypoaldosteronism natural history, complications and prognosis |
Hypoaldosteronism natural history, complications and prognosis in the news |
Blogs on Hypoaldosteronism natural history, complications and prognosis |
Risk calculators and risk factors for Hypoaldosteronism natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, hypoaldosteronism leads to hyperkalemia which can alter the function of cardiac conduction pathways. Depending upon the level of hyperkalemia, hypoaldosteronism can be a life threatening condition. Common complications of hypoaldosteronism include hyperkalemia, metabolic acidosis, hypotension, hypovolemia and hyponatremia. Depending on the extent of the hyperkalemia and underlying renal or adrenal condition at the time of diagnosis, the prognosis of hypoaldosteronism may vary. Prognosis is generally good for patients of hypoaldosteronism who receive treatment. Untreated patients risk having hyperkalemia which is associated with cardiac arrhythmias that can be fatal.
Natural History, Complications, and Prognosis
Natural History
- If left untreated, hypoaldosteronism can progress to hyperkalemia and hyponatremia with hypo or hyper volemia.
- Hyperkalemia is an acute life threatening condition since it can alter the electrical activity of the heart and lead to life threatening rhythms.
- Patients with severe hyperkalemia (>7.5 mmol/l) may present with bundle branch blocks or fascicular blocks.
- When serum potassium level ≥ 9 mEq/L, hyperkalemia may lead to ventricular fibrillation, PEA and even cardiac arrest.
- Hyponatremia is unusual in isolated hypoaldosteronism since under normal conditions cortisol leads to suppression of ADH. However, patients of adrenal insufficiency have decreased cortisol and aldosterone which may progress to hyponatremia.
- Aldosterone deficiency leads to decreased sodium and water absorption which predisposes to hypovolemia. However, patients with underlying conditions such as kidney disease or heart condition patient may be hypervolemic.
Complications
- Common complications of hypoaldosteronism include:
- Hyperkalemia
- Hypotension
- Hypovolemia
- Metabolic acidosis
- Hyponatremia
Prognosis
- Depending on the extent of the hyperkalemia and underlying renal or adrenal condition at the time of diagnosis, the prognosis of hypoaldosteronism may vary.
- Prognosis is generally good for patients of hypoaldosteronism who receive treatment.
- Untreated patients risk having hyperkalemia which is associated with cardiac arrhythmias that can be fatal.
- Patient having underlying renal insufficiency or diabetic nephropathy generally progresses to end stage stage renal disease. Drugs such as ACEi and ARBs which are the mainstay of treatment with diabetes and renal dysfunction are avoided in hypoaldosteronism since these may lead to hyperkalemia.